Mechanicsville, VA, United States of America

Jeffrey S Edmiston


Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovator Spotlight: Jeffrey S. Edmiston

Introduction: Jeffrey S. Edmiston, located in Mechanicsville, Virginia, is an accomplished inventor specializing in the field of respiratory health. With a focus on chronic obstructive pulmonary disease (COPD), his innovative contributions aim to enhance understanding and management of this pervasive health issue.

Latest Patents: Jeffrey Edmiston holds a significant patent for his work on biomarkers of lung function. His research identifies unique proteins associated with COPD that can distinguish between subjects likely to experience rapid decline (RPD) or slow decline (SLW) in lung function. Through comprehensive high-throughput proteomic approaches, Edmiston has identified thirty peptides linked to twenty-one unique proteins, which exhibit linear associations with annualized rates of lung function decline among smokers, particularly those diagnosed with COPD. Furthermore, by employing various statistical methodologies, he discovered fifty-five peptides corresponding to thirty-three unique proteins that effectively differentiate between the RPD and SLW groups.

Career Highlights: As an innovator, Jeffrey Edmiston has made significant strides in understanding the biological underpinnings of lung function and disease progression in COPD patients. His work with Lineagen, Inc., where he continues to apply his expertise in proteomics, demonstrates his commitment to advancing medical research and improving patient outcomes.

Collaborations: Edmiston collaborates with noted colleagues Jason W. Flora and Barbara K. Zedler, further fostering a collaborative research environment that encourages innovation and the sharing of ideas. These partnerships enhance the potential for significant breakthroughs in lung health research.

Conclusion: Jeffrey S. Edmiston's contributions to the field of respiratory health through his patent regarding biomarkers for lung function underscore the importance of innovation in tackling chronic diseases such as COPD. His work not only highlights the complexity of lung function decline but also emphasizes the potential for novel therapeutic approaches, benefiting countless individuals affected by this condition.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…